- $50.68bn
- $58.10bn
- $129.66bn
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says (updated)
CMS says 71% of Medicare Advantage prescription drug enrollees in 4-star or higher plans for 2027
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
US STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
U.S. STOCKS ON THE MOVE-Intel, Vaxcyte, Constellation Brands
Cantor upgrades Humana, sees strong Medicare margin recovery in 2027
Most Americans support switch to Medicare for all health insurance
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
Health insurers fall after UnitedHealthcare, Aetna announce 2027 plan designs
Brief: Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027
Brief: Humana Launches 2027 Medicare Advantage Plans In About 2,600 Counties Across 45 States & Washington D.C.
UnitedHealthcare, Aetna say 2027 Medicare Advantage plans to offer more limited provider networks
Medicare Advantage premiums expected to drop more than 16% in 2027, CMS projects
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
CVS Health's Aetna to streamline cancer treatment approvals